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Amphiphilic A2(BC)2 miktoarm star polymers [poly(ε-caprolactone)]2-[poly(2-(diethylamino)ethyl methacrylate)-
b- poly(poly(ethylene glycol) methyl ether methacrylate)]2 [(PCL)2(PDEA-b-PPEGMA)2] were developed by a
combination of ring opening polymerization (ROP) and continuous activators regenerated by electron transfer
atom transfer radical polymerization (ARGET ATRP). The critical micelle concentration (CMC) values were extremely
low (0.0024 to 0.0043 mg/mL), depending on the architecture of the polymers. The self-assembled empty and
doxorubicin (DOX)-loaded micelles were spherical in morphologies, and the average sizes were about 63 and
110 nm. The release of DOX at pH 5.0 was much faster than that at pH 6.5 and pH 7.4. Moreover, DOX-loaded
micelles could effectively inhibit the growth of cancer cells HepG2 with IC50 of 2.0 μg/mL. Intracellular uptake
demonstrated that DOX was delivered into the cells effectively after the cells were incubated with DOX-loaded
micelles. Therefore, the pH-sensitive (PCL)2(PDEA-b-PPEGMA)2 micelles could be a prospective candidate as
anticancer drug carrier for hydrophobic drugs with sustained release behavior.
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Over the past several decades, great efforts have been made
to improve the available anticancer therapies. Unfortu-
nately, the majority of chemotherapy, which has a substan-
tial hydrophobic component, is usually hampered by
problems such as lack of tumor selectivity, poor water solu-
bility, uncontrollable pharmacokinetic processes, and the
possible incurrence of severe side effects [1-3]. To improve
therapeutic efficacy as well as minimize side effects, tre-
mendous drug delivery vehicles based on polymer micelles
have been exploited. Polymeric micelles, with nanoscopic
core-shell structures self-assembled by amphiphilic copoly-
mers, have attracted the attention of researchers as hydro-
phobic drug carriers owing to their unique properties,
including higher loading capacity, improved water solubil-
ity, passive and active targeting capabilities, prolonged* Correspondence: celjzh@scut.edu.cn
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in any medium, provided the original work is pin vivo circulation duration, enhanced therapeutic efficacy,
and negligible side effects [4-8].
In recent years, stimulus-responsive polymer materials,
which can accept appropriate changes in response to
specific environmental fluctuations or imposed varia-
tions of control parameters, are recognized as one of the
most promising modalities in drug delivery systems due
to their unique behaviors and intelligent properties
[9,10]. Although many types of stimuli have been exten-
sively studied as drug carriers, including their responsive
abilities to pH, temperature, redox, light, ionic strength,
enzyme and so forth, a variety of the researches have fo-
cused on utilizing pH-responsive polymeric micelles
[11-15]. The vital reason for the promising use of pH-
responsive polymeric micelles aiming at tumor-targeting
is attributed to the different conditions in normal tissues
and tumor tissues. Since the intracellular pH values of
endosomal and lysosomal environment are typically
acidic (pH 5.0 to 6.0 and 4.5 to 5.0, respectively) and the
extracellular pH values in tumor tissues are around 6.5pen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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the normal physiological environment. An ideal antican-
cer drug pH-responsive polymeric micelles can escape
releasing of drug in normal tissues (pH 7.4) and
destabilize at an early endosomal pH 6.0 [16-18]. Poly(2-
(diethylamino)ethyl methacrylate) (PDEA), a kind of cat-
ionic polyelectrolyte with a pKb of 6.9, can be soluble in
water under pH 6.9 but become hydrophobic and insol-
uble at normal physiological conditions. The responsive-
ness to the weakly acidic condition indicates that PDEA
copolymers can be latent pH-sensitive polymeric mi-
celles for tumor-targeting drug delivery [16,19].
Star-shaped polymers, one kind of dendritic polymers
with well-defined architecture and multiple polymer
chains emanating from the central core, have similar topo-
logical structures to polymeric micelles and can form
more stable nanoscale assemblies in selective solvents, as
compared with the corresponding linear block analogues.
Hence, star polymers have been actively investigated cur-
rently for potential utility as nanoreactors, catalysts, sen-
sors, polymer and electrolytes and in biomedical and
therapeutic applications [20-23]. Amphiphilic star polymer
can be divided into amphiphilic homo-arm star block
polymer (AB)n and amphiphilic miktoarm star polymers
(AmBn). With same polymer chains emanating from the
central core, amphiphilic homo-arm star block poly-
mers have been prepared and used particularly in drug
and gene delivery [24,25]. For example, He and coworkers
synthesized well-defined four-arm PEO-b-PDEAEMA,
which could form pH-responsive micelles. And the four-
arm PEO-b-PDEAEMA micelles were suggested high
gene transfection efficiency for the delivery of DNA
[26,27]. Knop's group developed amphiphilic star-shaped
block copolymers (PCLa-b-POEGMAb)4 for loading the
novel fungicide to provoke an inhibition of the growth of
different fungal strains [28]. A series of amphiphilic four-
and six-armed star triblock copolymers 4/6AS-PCL-b-
PDEAEMA-b-PPEGMA were also developed recently by
our group for the intracellular delivery of the anticancer
drug doxorubicin (DOX) [29].
Amphiphilic miktoarm star polymers with at least two
different polymer chains emanating from the central
core such as A2B2, A3B3, A2B, A3B, ABC, AB2C2, ABCD,
etc., especially for A2B2 and A3B3, have been used in
self-assembly and responsive behavior. Gou's group syn-
thesized a series of A2B2 miktoarm star copolymer C4S
(PCL)2-(PEG)2, which could self-assemble into various
morphologies in aqueous solution controlled by both the
macromolecular architectures and the compositions of
the copolymer [30]. Well-defined (PNIPAAM)2-(PNVP-
b-PAA)2 and (PNIPAAM-b-PAA)2-(PNVP)2 were devel-
oped by Zhang's group, and by tuning pH values and
temperatures of aqueous solution of these two copoly-
mers, three types of micellar aggregates and the unimerstate could undergo reversible switch on and off in size
and morphology [31]. However, limited work of A2B2
and A3B3 type miktoarm polymers was reported on drug
and gene delivery.
In the current work, we report on the fabrication of
amphiphilic A2(BC)2 miktoarm poly(ε-caprolactone)2-[poly
(2-(diethylamino)ethyl methacrylate)-b-poly(poly (ethylene
glycol) methyl ether methacrylate)]2 [(PCL)2(PDEA-b-
PPEGMA)2] polymeric micelles as an integrated plat-
form for intracellular delivery of the anticancer drug
doxorubicin (Figure 1). Miktoarm star polymers (PCL)2
(PDEA-b-PPEGMA)2 were synthesized by using the difunc-
tional initiator for sequential ring opening polymerization
(ROP) of ε-CL and continuous activators regenerated by
electron transfer atom transfer radical polymerization
(ARGETATRP) of DEA and PEGMA. In aqueous solution,
(PCL)2(PDEA-b-PPEGMA)2 could exist as structurally
stable micelles possessing a hydrophobic PCL inner core,
a pH-sensitive PDEA middle layer, and a hydrophilic
PPEGMA outer shell. The pH-responsive PDEA layer is
hydrophobic and collapses on the core at the physiological
pH (7.4) which can prevent the premature burst drug re-
lease, but it becomes highly positively charged by proton-
ation of the pendant tertiary amine groups and could lead
the micelles to be adsorbed onto negatively charged cell
membranes and subsequently endocytosed by tumor cells
at tumor extracellular pH. Once internalized and trans-
ferred to a lysosome, the further charged PDEA can lead to
faster release of the entrapped drug into the cytoplasm and
nucleus [16]. Anti-tumor activities and intracellular uptake




Pentaerythritol was dried under reduced pressure over-
night prior to use. ε-Caprolactone (ε-CL, 99%, Aldrich,
St. Louis, MO, USA) was dried over calcium hydride
and distilled under reduced pressure before use. 2-
(Diethylamino)ethyl methacrylate (DEA, TCI-EP) was
distilled from calcium hydride and stored under argon
at −20°C. Poly(ethylene glycol) methyl ether methacryl-
ate (PEGMA, Mn = 475 Da, 99%, Aldrich) was purified
by passing through a column filled with neutral alumina
to remove inhibitor. Tetrahydrofuran (THF) was dried
over sodium using benzophenone as a dryness indicator
and distilled under nitrogen prior to use. Toluene was
distilled from calcium hydride. Doxorubicin hydrochlor-
ide (DOX∙HCl) was purchased from Beijing Huafeng
United Technology Co., Ltd., Beijing, China. Dulbecco's
modified Eagle medium (DMEM), fetal bovine serum
(FBS), penicillin, and streptomycin were all purchased
from Invitrogen, Carlsbad, CA, USA. HepG2 cells were
purchased from the American Type Culture Collection
Figure 1 Illustration of DOX-loaded (PCL)2(PDEA-b-PPEGMA)2 micelles formation and intracellular DOX delivery triggered by
endosomal pH (pH 5.0).
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recommended conditions according to the supplier. 3-
(4,5-Dimethyltlliazol-2-yl)-2,5-diphenyltetrazoxium brom-
ide (MTT) and Hoechst 33324 were purchased from
Sigma Chemical Co. Pyrene (99%, Aldrich), 2-bromoisobutyryl
bromide (98%, Alfa Aesar, Ward Hill, MA, USA), 1,1,4,7,
10,10-hexamethyltriethylenetetramine (HMTETA, 99%,
Aldrich), paraformaldehyde (99%, Aldrich), CuBr2, metha-
nol, stannous octoate (Sn(Oct)2), triethylamine (TEA), di-
methyl sulfoxide (DMSO), acetone, and all other reagents
were used as received.
Synthesis of difunctional initiator pentaerythritol
bis(2-bromoisobutyrate) [(OH)2-Br2]
(OH)2-Br2 was synthesized as follows: to a flame-dried
250 mL Schlenk flask with a magnetic stirring bar, whichwas evacuated and flushed with argon thrice, pentaery-
thritol (6.80 g, 0.05 mmol), anhydrous THF (150 mL),
and TEA (13.89 mL, 0.10 mmol) were added in turn
at 0°C. Then, 2-bromoisobutyryl bromide (12.36 mL,
0.10 mmol) was injected dropwise for a period of 2 h
with vigorous stirring. The reaction was continued at 0°C
for 5 h and then at room temperature for another 24 h.
The reaction mixture was cooled, extracted with 300 mL
diethyl ether thrice, and then the diethyl ether layer
was washed successively with water, saturated NaHCO3,
and water and dried over MgSO4 overnight followed by
rotary evaporation to remove the solvent. The colorless
liquid product (OH)2-Br2 was collected by distillation
under reduced pressure. 1H NMR (d6-DMSO as solvent,
in Additional file 1: Figure S1): −O-CH2- δ = 3.65 ppm
(4H), −COO-CH2- δ = 4.31 ppm (4H), −C(CH3)2-Br δ =
Lin et al. Nanoscale Research Letters 2014, 9:243 Page 4 of 12
http://www.nanoscalereslett.com/content/9/1/2431.96 ppm (12H); Element Analysis, calculated (%): C 35.94,
H 5.37; found (%): C 35.83, H 4.85.
Synthesis of bromide-terminated two-arm poly(ε-caprolactone)
macroinitiator [(PCL)2-Br2]
(PCL)2-Br2 was synthesized by ROP of ε-CL using (OH)2-
Br2 as initiator [32,33]. Typically, a flame-dried 100 mL
Schlenk flask equipped with a magnetic stirring bar was
charged with difunctional initiator [(OH)2-Br2] (0.434 g,
1 mmol), and the flask was evacuated and flushed with
argon three times. Subsequently, the freshly distilled ε-CL
(6 g) and a required amount of Sn(Oct)2 (0.1 wt.% of ε-
CL, 0.006 g) solution were injected into the flask by syr-
inge and three ‘freeze-pump-thaw’ cycles were performed
to remove any oxygen from the solution. The flask was
immersed into a thermostated oil bath at 130°C for 24 h.
The crude polymer was dissolved in approximately 50 mL
THF followed by adding dropwise to 500 mL water/
methanol (1:1, v/v) mixture to precipitate the product,
which was collected and dried under vacuum for 24 h,
resulting in powdery (PCL)2-Br2.
Synthesis of A2(BC)2 miktoarm star polymers (PCL)2(PDEA-
b-PPEGMA)2
The continuous ARGET ATRP of DEA and PEGMA was
in situ monitored by ReactIR iC10 (Metter-Toledo Auto-
Chem, Columbia, MD, USA) equipped with a light con-
duit and DiComp (diamond composite) insertion probe
[34,35]. The FTIR spectra were collected every minute,
and the change of absorbance at 938 cm−1 (=CH2 wags of
the DEA and PEGMA) was used to provide the conver-
sion of monomers during the polymerization calculated
by ReactIR 4.1 software. In a typical synthesis procedure, a
previously dried 100 mL Schlenk flask equipped with a
magnetic stirring bar was charged with (PCL)2-Br2 (4.0 g,
0.8 mmol) and CuBr2 (0.0143 g, 0.064 mmol). The real-
time FTIR probe was introduced into the flask, and the
flask was then evacuated and flushed with argon thrice.
Anhydrous toluene (18 mL), DEA (4.8 g), and ligand
HMTETA (0.164 mL, 0.64 mmol) were injected into the
flask using degassed syringes in order. The mixture was
stirred for 10 min, and a required amount of Sn(Oct)2
(0.259 g, 0.64 mmol) solution in toluene (2 mL) was added
into the flask by syringe. The flask was placed in a pre-
heated oil bath maintained at 70°C, and the FTIR spectra
were collected at the time. After 5 h, the absorbance of
938 cm−1 was kept almost constant and the second mono-
mer PEGMA (Mn = 475, 6.4 g) was then introduced
by syringe to continue the polymerization for another
20 h. Then, the flask was removed from the oil bath and
cooled to room temperature. THF (50 mL) was added into
the flask, and the mixture was then passed through a
neutral alumina column to remove the catalyst. After re-
moving the catalyst, the product was recovered by beingprecipitated into tenfold excess of n-hexane, filtered, and
finally dried under vacuum for 24 h.
CMC measurement
The critical micelle concentration (CMC) values of (PCL)2
(PDEA-b-PPEGMA)2 were determined by the fluorescence
probe technique using pyrene as a fluorescence probe. Pyr-
ene dissolved in acetone was added into deionized water
(pH 7.4) to make a concentration of 12 × 10−7 M following
by removed acetone 2 h through evaporation. The final
concentration of pyrene was adjusted to 6 × 10−7 M. The
(PCL)2-(PDEA-b-PPEGMA)2 (5 mg) was first dissolved into
50 mL deionized water and then diluted to a series of con-
centrations from 0.0001 to 0.1 mg/mL with deionized water.
Then, 10 mL of polymer solutions at different concentra-
tions were added to the pyrene-filmed vials, respectively,
and the combined solutions were equilibrated at room
temperature in the dark for 24 h before measurement. The
fluorescence excitation spectra of polymer/pyrene solutions
were measured and used for determining the CMC values.
Preparation of empty and DOX-loaded micelles
The empty and DOX-loaded (PCL)2(PDEA-b-PPEGMA)2
self-assembled micelles were prepared according to the dia-
filtration method. Typically, (PCL)2(PDEA-b-PPEGMA)2
(40 mg) was dissolved in 20 mL of DMSO (40 mL for
empty micelles) at room temperature 25°C, followed by
adding a predetermined amount of DOX∙HCl (10 mg) and
double molar amount of TEA in another 20 mL of DMSO
and then stirring for 4 h. Then, the mixture solution was
transferred to dialysis bag (MWCO= 3.5 kDa) and dialyzed
against deionized water for 24 h to remove the organic sol-
vents and free DOX. The deionized water was changed
every 4 h for the first 8 h and then replaced every 6 h. After
dialysis, the micelles were filtered by a membrane filter
(0.45-μm pore) to remove aggregated particles. Then, half
of the empty and DOX-loaded micelles were used to study
the pH-responsive behavior by the addition of NaOH or
HCl (0.01 M) solution. And the remaining empty and
DOX-loaded micelles were collected by freeze-drying to ob-
tain dried product. The received white powder was stored
at −20°C until further experiments. The values of Dhs and
morphologies of the empty and DOX-loaded micelles were
monitored by DLS and TEM. DOX-loaded micelles were
dissolved in 10 mL of DMSO under vigorous vortexing and
analyzed by UV-vis spectrophotometer (UV-2450, Shi-
madzu, Kyoto, Japan) at 480 nm to obtain DOX loading
content (LC), wherein a calibration curve was obtained with
DOX-DMSO solutions with different DOX concentrations.
The LC values were around 10% in the current work.
In vitro DOX release
The release profiles of DOX from the DOX-loaded micelles
at a concentration of 1 mg/mL were studied in different
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loaded micelles were immersed in 5 mL of PBS buffer
(pH 7.4 or pH 6.5) or acetate buffer (pH 5.0) and
then placed in a pre-swollen cellulose membrane bag
(MWCO= 3.5 kDa). The whole bag was placed into 40 mL
of PBS or acetate buffer with constant shaking (100 rpm) at
37°C (Dissolution Tester RCZ-8B, TDTF, Tianjin, China).
At predetermined time intervals, a 4-mL buffer solution
outside the dialysis bag was extracted and it was replaced
by an equal volume of fresh media to keep the sink condi-
tion. The amounts of released DOX in different buffers
were monitored by UV-vis spectrophotometer at 480 nm.
Each experiment was done in triplicate, and the results
were the average data.
Cell culture and cytotoxicity assay
The in vitro cytotoxicity tests of the free DOX, empty, and
DOX-loaded micelles were evaluated by the standard
MTT assay against HepG2 cells. The HepG2 cells were
first seeded on a 96-well plate at an initial density of 1 ×
104 cells/well in DMEM supplemented with 10% FBS,
penicillin (100 units/mL), and streptomycin (100 μg/mL)
at 37°C in a CO2 (5%) incubator for 3 days to reach 60%
to 70% confluence. Then, the empty micelles with the final
concentration from 1 to 400 μg/mL were added. After
48 h, 20 μL of MTT solution (5 mg/mL in PBS buffer)
was added into each well and incubated for another
4 h. Afterwards, the medium in each well was then re-
moved and 200 μL of DMSO was added to dissolve the
internalized purple formazan crystals. The absorbance was
measured at a wavelength of 490 nm by a microplate
reader (Multiskan Spectrum, Thermo Scientific, Vantaa,
Finland). Data were expressed as average ± SD (n = 3).
HepG2 cells were incubated with free DOX and DOX-
loaded micelles with DOX final concentration from 0.1
to 20 μg/mL in culture medium. After 24 and 48 h,
20 μL of MTT solution (5 mg/mL in PBS buffer) was
added into each well and incubated for another 4 h.
Afterwards, the culture medium was removed, the ob-
tained crystals were dissolved in 200 μL of DMSO,
and the absorbance was measured at a wavelength of
490 nm by a microplate reader. Data were expressed as
average ± SD (n = 3).
CLSM observation
Confocal laser scanning microscopy (CLSM, Zeiss, LSM
510, Oberkochen, Germany) was employed to examine
the intracellular distribution of DOX. HepG2 cells were
seeded on slides on a 6-well plate at a density of 4 × 105
cells/well in 2 mL of DMEM and were cultured for 24 h
at 37°C in 5% CO2 atmosphere. The cells were then in-
cubated with free DOX and DOX-loaded micelles at
a final DOX concentration of 50 μg/mL in DMEM for
4 or 24 h at 37°C. At each predetermined time, theculture media were removed and the cells were washed
with PBS (1 min × 3) to remove the DOX-loaded mi-
celles that were not ingested by the cells. Subsequently,
the cells were fixed with 4% (w/v) paraformaldehyde
aqueous solution for 30 min at room temperature. The
slides were then rinsed with PBS (2 min × 3). Finally,
the cells were stained with Hoechst 33324 (5 mg/mL in
PBS) at 37°C for 15 min, and the slides were rinsed
with PBS (2 min × 3). The prepared slides were ob-
tained by CLSM.
Characterization
1H NMR spectra measurements were examined in d6-
DMSO and CDCl3 at 25°C using Bruker AVANCE ΙΙΙ
400 (Madison, WI, USA) operating at 400 MHz. The
number average molecular weight (Mn) and polydisper-
sity index (Mw/Mn) were determined by gel permeation
chromatography (GPC) adopting an Agilent 1200 series
GPC system (Santa Clara, CA, USA) equipped with a LC
quant pump, PL gel 5 mm 500, 104, and 105 Å columns
in series, and RI detector. The column system was cali-
brated with a set of monodisperse polystyrene standards
using HPLC grade THF as mobile phase with a flow rate
of 1.0 mL/min at 30°C. Fluorescence spectra were re-
corded using a fluorescence spectrophotometer (F-4500,
Hitachi, Chiyoda-ku, Japan). The hydrodynamic diameter
(Dh) and distribution (PDI) of micelles were measured by
dynamic light scattering (DLS, Malvern Zetasizer Nano S,
Malvern, WR, UK). Morphologies of micelles were investi-
gated by transmission electron microscopy (TEM, Hitachi
H-7650) operating at 80 kV.
Results and discussion
Synthesis and characterization of (PCL)2(PDEA-b-PPEGMA)2
A2(BC)2 miktoarm star polymers (PCL)2(PDEA-b-PPEGMA)2
were synthesized by using the difunctional initiator for
sequential ROP of ε-CL and continuous ARGET ATRP
of DEA and PEGMA, as illustrated in Figure 1. Repre-
sentative 1H NMR spectra of (PCL)2-Br2 and (PCL)2
(PDEA-b-PPEGMA)2 were depicted in Figure 2, and all
of the peaks corresponding to characteristic hydrogen
atoms were labeled. In Figure 2A, the characteristic sig-
nals at 1.96, 3.65, and 4.31 ppm were assigned, respect-
ively, to -C(CH3)2-Br, −O-CH2-, and -COO-CH2- in the
pentaerythritol unit, whereas the characteristic signals
at 1.40, 1.66, 2.33, and 4.10 ppm were from -CH2- protons
of PCL backbone. In Figure 2B, the signals at 0.90 and
1.82 to 1.92 ppm are assigned respectively to -CCH3 and
-CH2- of methacrylate backbone. The signals at 2.71 and
4.01 ppm were the characteristic resonances of the coter-
minous two methylene protons of -CH2CH2- in DEA unit,
and the signals at 1.05 and 2.59 ppm belonged respectively
to the end methyl and methylene protons of -CH2CH3
in DEA unit. The characteristic PEGMA peaks at 3.40,
Figure 2 1H NMR spectra of (PCL)2-Br2 (A) and (PCL)2(PDEA-b-PPEGMA)2 (B) in CDCl3.
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and -COO-CH2- protons, respectively. The degree of
polymerization of PCL (x), PDEA (y) and PPEGMA (z)
and the molecular weights (Mn,NMR) were calculated from
the integration ratio values of signal (g) to (a) (Ig/Ia), signal
(n) to (g) (In/Ig), and signal (r) to (g) (Ir/Ig), respectively, as
summarized in Table 1.
Figure 3 showed that the reaction process could be
easily in situ monitored by ReactIR iC10 via detecting
the change of absorbance at 938 cm−1 (=CH2 wags of
the DEA and PEGMA) [36,37]. It could be seen that the
absorbance at 938 cm−1 decreased as the polymerization
of DEA proceeded. Since the absorbance of DEA almost
kept constant at 5 h, the second monomer PEGMA was
added to continue the polymerization for another 20 h
until the absorbance remained unchanged again in
Figure 3A. From the change of absorbance at 938 cm−1 inTable 1 GPC and 1H NMR data of (PCL)2(PDEA-b-PPEGMA)2 po








aThe subscripts of PCL, PDEA and PPEGMA were the DP of PCL (x), PDEA (y) and PP
ccalculated by the equations Mn, NMR = (114 × x +185 × y + 475 × z ) × 2 + 434
; dcalcusitu monitored by react infrared spectroscopy, we could
calculate the conversions of DEA and PEGMA during the
ARGET ATRP presented in Figure 3B. And thus the mo-
lecular weights (Mn, ReactIR) of the (PCL)2(PDEA-b-
PPEGMA)2 could be calculated from the conversions of
DEA and PEGMA, which was seldom reported before.
The Mn, ReactIR listed in Table 1 were in good agreement
with the Mn,NMR, suggesting that (PCL)2(PDEA-b-
PPEGMA)2 with different PCL/PDEA/PPEGMA con-
tents were well-defined. The semilogarithmic plots of ln
([M]o/[M]) vs. time from Figure 3C showed linear time
dependency for both DEA and PEGMA during their
polymerization, indicating that a good control of the
polymerization process was achieved in the current work.
The molecular weights of the serial (PCL)2(PDEA-b-
PPEGMA)2 were determined by GPC and summarized











EGMA (z) calculated from 1H NMR spectrum; bmeasured by GPC in THF;
lated by monomer conversion from the ReactIR.
Figure 3 In situ monitored by ReactIR iC10. The absorbance at 938 cm−1 (=CH2 wags) (A) monomer conversion versus time curves (B) and
kinetic plots (C) for continuous ARGET ATRP of DEA and PEGMA.
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metric distribution and the values of Mw/Mn were below
1.50, which are acceptable for further application of deliv-
ering drugs. It was also found that GPC analysis for
(PCL)2(PDEA-b-PPEGMA)2 tended to underestimate the
molecular weight (which was typically smaller) as com-
pared to their linear counterpart due to the reduced
hydrodynamic volumes. The characterization of the molar
masses of star polymers by GPC is not straightforward.
Since standard samples with exactly the same topology
and with known molar masses do not exist, the calibration
with narrow standards cannot be applied [38,39].
Characterization of the empty and DOX-loaded micelles
The formation of micelles self-assembled from (PCL)2
(PDEA-b-PPEGMA)2 in aqueous phase was verified using
a fluorescence technique with pyrene as a fluorescence
probe [40-42]. When the (PCL)2(PDEA-b-PPEGMA)2 mi-
celles were formed, pyrene molecules preferably located
inside or closed to the hydrophobic core of micelles,
and consequently, the photophysical characteristics
were changed. In the excitation spectra of polymer/pyrene
solutions (see Additional file 1: Figure S3), with increasing
the concentrations of (PCL)2(PDEA-b-PPEGMA)2, the
fluorescence intensity increased and the (0, 0) band shifted
from 336 to 339 nm in the excitation spectra of pyrene.
The ratios of I339 to I336 were plotted against (PCL)2
(PDEA-b-PPEGMA)2 concentrations, which can be seen in
Figure 4. The CMC values of (PCL)2(PDEA-b-PPEGMA)2
were determined from the crossover points which were in
the range of 0.0024 to 0.0043 mg/mL, increasing as the
weight fraction of PCL decreased [43]. For example, the
CMC values 0.0043, 0.0040, and 0.0024 mg/mL of (PCL24)2
(PDEA16-b-PPEGMA19)2, (PCL32)2(PDEA20-b-PPEGMA19)2,
and (PCL38)2(PDEA17-b-PPEGMA9)2, respectively, were
decreased in order. Moreover, as the samples were pre-
pared with deionized water (pH 7.4), most tertiary amine
residues of PDEA were still deprotonated and exhibited as
hydrophobic. Hence, taken the hydrophobicity of PDEAblock into the consideration, the CMC of (PCL24)2
(PDEA37-b-PPEGMA15)2 (0.0030 mg/mL) was much
lower than the CMC of (PCL24)2(PDEA16-b-PPEGMA19)2
(0.0043 mg/mL).
The (PCL24)2(PDEA16-b-PPEGMA19)2 was used as an
example to encapsulate hydrophobic drug DOX. The Dh
of the empty micelles self-assembled from the polymer
(PCL24)2(PDEA16-b-PPEGMA19)2 at pH 7.4 was 63 nm
observed by DLS measurement. After drug loading, the
DOX-loaded micelles showed a larger size than the
empty micelles with Dhs around 110 nm, which were
shown in Figure 5A,B. It was because hydrophobic DOX
promoted hydrophobic interaction among the PCL
chains and thus led to an increase in aggregation. The
micellar size maintained narrow unimodal distribution,
indicating good physical performance of the assembled
micelles. Figure 5C,D showed the TEM images of empty
micelles, and DOX-loaded micelles were spherical in
shape (pH 7.4). It is worthwhile to note that the average
sizes shown in TEM images were almost in accordance
with the DLS results. The empty and DOX-loaded
micelles possessed positive charges in pH 7.4 due to
the pendant tertiary amine groups in the PDEA chains
(Figure 6B). The highly charged character of the (PCL)2
(PDEA-b-PPEGMA)2 micelles can prevent the aggrega-
tion of micelles, extend blood circulation times, increase
the interactions between micelles and cell membranes
which can facilitate penetrating of cell membranes [44,45].
The variations of the Dhs and zeta potentials of the
empty micelles and DOX-loaded micelles were investigated
from the facile pH adjusting. As shown in Figure 6, when
decreasing pH from 10 to 2, the Dhs and zeta potentials in-
creased gradually followed by abrupt descend because the
micelles underwent shrinking-swelling-dissociating con-
formational transition. The Dhs of the micelles showed
slightly increase owing to incorporation of DOX molecules
in the core of micelles compared to the empty micelles.
At higher pH above 8, both micelles were in a compact,
collapsed form with the Dhs remained almost constant
Figure 4 Graphs of intensity ratios (I339/I336) as function of logarithm of (PCL)2(PDEA-b-PPEGMA)2 concentrations in aqueous solution.
Figure 5 Size distribution determined with DLS (A,B) and TEM (C,D) for empty micelles (A,C) and DOX-loaded micelles (B,D).
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Figure 6 Dh (A) and zeta potential (B) results of empty micelles and DOX-loaded micelles at different pH.
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zeta potentials at higher pH (like pH 10) were negative
with increasing OH− in the solution. As the pH values were
ranging from 8 to 4, both micelles exhibited the gradually
stretched conformation with significant increase of Dhs
and zeta potentials due to gradual protonation of DEA
block and the increasing hydrophilicity of PDEA. At pH<
4, the Dhs and zeta potentials of both micelle solutions
showed sharp decrease, indicating that the PDEA segments
were fully protonated with imparting a hydrophilic charac-
teristic and the extremely strong electrostatic repulsion be-
tween polymer chains, which might cause the decrease of
the aggregation number of the polymers or even slight dis-
sociation of the micelle structures [29].
In vitro drug release profiles and cell experiments
The in vitro drug release profiles of DOX-loaded micelles
were evaluated at 37°C under different pH (pH 7.4,
pH 6.5, and pH 5.0) to explore the effects of pH-responsive
behavior on controlled drug delivery, as shown in Figure 7.Figure 7 In vitro drug release profiles of DOX-loaded micelles
at pH 7.4, 6.5, and 5.0.The release rates significantly accelerated as the pH de-
creased from 7.4 to 5.0, which demonstrated that the pH of
medium had a strong effect on the DOX release from the
(PCL)2(PDEA-b-PPEGMA)2 micelles. At pH 7.4, only 22%
of DOX was released in 12 h and then the release rate
was almost constant, and approximately 36% of DOX
was released after 96 h. At pH 6.5, the release rates of DOX
accelerated to a certain extent with about 50% of DOX was
released after 96 h, due to the partial protonation of the ter-
tiary amine groups of DEA contributed to the slight swell
of micelles. At pH 5.0, as the most of the tertiary amine
groups of DEA had been protonated, the distinctly de-
creased hydrophobicity of the micellar core and greatly
increased electrostatic repulsion between DEA moieties
contributed to the greater degree of swell or even slight
dissociation of micelles, the release rates of DOX were
drastically accelerated, the cumulative release of DOX was
40% in 12 h, 60% in 48 h, and almost 82% in 96 h. More-
over, initial burst drug release was not observed.
To deeply apprehend the pH-triggered hydrophobic
drug release behavior, a semi-empirical equation (1)
established by Siepmann and Peppas [46] is considered
to analyze the drug release mechanism from the micelles






¼ n logt þ logk ð1Þ
Where Mt and M∞ are the absolute cumulative
amount of drug released at time t and infinite time re-
spectively, n is the release exponent indicating the drug
release mechanism and k is a constant incorporating
structural and geometric characteristic of the device. For
spherical particles, the value of n is equal to 0.43 for
Fickian diffusion and 0.85 for non-Fickian mechanism,
n < 0.43 is due to the combination of diffusion and ero-
sion control, and 0.43 < n < 0.85 corresponds to anomal-
ous transport mechanism [48].
Figure 8 In vitro cytotoxicity. Empty micelles after 48 h. At different concentrations of polymer (A) and DOX-loaded micelles after 24 h and
48 h (B) incubation at different concentrations of DOX determined by MTT assay against HepG2 cells. The standard deviation for each data point
was averaged three samples (n = 3).
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n, rate constant k, and the correlation coefficient R2,
were shown in Additional file 1: Table S1. The release of
DOX at different pH conditions were divided into two
stages with good linearity, one is from 0 to 12 h, and the
other is from 12 to 96 h. The results showed that the
pH values have major influence on DOX release process.
In the first 12 h, the n values of pH 7.4, 6.5, and 5.0 were
0.28, 0.49, and 0.63, respectively. The drug release rates
were significantly accelerated and the mechanism of
DOX transformed from the combination of diffusion
and erosion control to anomalous transport mechanism
action when changing pH from 7.4 to 5.0. After 12 h,
drug release was controlled by anomalous transportFigure 9 CLSM images of HepG2 cells. For incubation with DOX-loaded
DOX; blue, Hoechst 33324. Scale bar, 20 μm).mechanism action with the n values of pH 7.4, 6.5, and
5.0 were 0.48, 0.49, and 0.50, respectively.
The cytotoxicity of free DOX, empty micelles and
DOX-loaded micelles against HepG2 (hepatocellular car-
cinoma) cells were determined by MTT assay [8,49,50].
It should be noted that the empty micelles exhibited
negligible cytotoxicity, as about 80% viability was ob-
served even at their highest concentration (400 μg/mL)
after 48 h incubation in Figure 8A. Figure 8B showed
the viability of HepG2 cells in the presence of free DOX
and DOX-loaded micelles. The IC50 values were 1.6 and
2.0 μg/mL for free DOX and DOX-loaded micelles after
48 h incubation, respectively, indicating that the DOX-
loaded micelles could exhibit similar antitumor activitiesmicelles. For 4 h (A), 24 h (B), and with free DOX for (C) 24 h (red,
Lin et al. Nanoscale Research Letters 2014, 9:243 Page 11 of 12
http://www.nanoscalereslett.com/content/9/1/243to free DOX. Compared with free DOX, DOX-loaded mi-
celles exhibited much lower cytotoxicity to HepG2 cells at
the same dose of DOX, which was mostly due to the con-
trolled and incomplete release of DOX from micelles in
this time frame, as confirmed with in vitro DOX release.
The cellular uptake of the micelles was further examined
by CLSM measurements. HepG2 cells were cultured with
free DOX and DOX-loaded micelles (50 μg/mL of DOX
concentration) at 37°C for 4 and 24 h, respectively. The red
fluorescence was mainly observed in cytoplasm with a
small portion in the nuclei after 4 h (Figure 9A). With fur-
ther incubation for 24 h in Figure 9B, intense DOX red
fluorescence was almost localized in the nuclei, but not so
strong as that of free DOX (Figure 9C), indicating that
DOX-loaded micelles might not enter the nuclei as quickly
as the free DOX. Because DOX is a small molecule, it
can be quickly transported into cells and enter the nuclei
through a passive diffusion mechanism. However, DOX-
loaded micelles are internalized through an endocytotic
pathway and only the released DOX can enter nuclei.
Conclusions
Serial amphiphilic miktoarm star polymers (PCL)2
(PDEAEMA-b-PPEGMA)2 were successfully prepared
by a combination of ROP and continuous ARGET ATRP.
A good first-order kinetic characteristic was observed
for the continuous ARGET ATRP of DEA and PEGMA.
The CMC values of (PCL)2(PDEA-b-PPEGMA)2 were
extremely low (0.0024 to 0.0043 mg/mL). The self-
assembled empty and DOX-loaded micelles were spherical
in morphologies with average sizes of 63 and 110 nm de-
pending on the architecture of the copolymers. The pH
responsiveness and in vitro release properties from the mi-
celles exhibited desired pH dependence owing to the
protonation of tertiary amine groups of DEA. The in vitro
release study showed that the release of DOX at pH 5.0
was much faster than that at pH 7.4 and pH 6.5. More-
over, in vitro cytotoxicity of DOX-loaded micelles sug-
gested that they could effectively inhibit the growth of
cancer cells HepG2 with IC50 of 2.0 μg/mL, indicating that
the DOX-loaded (PCL)2(PDEA-b-PPEGMA)2 micelles
could exhibit similar antitumor activities to free DOX.
Intracellular uptake demonstrated that DOX was delivered
into the cells effectively after the cells were incubated with
DOX-loaded micelles. The characteristics demonstrated
that these pH-sensitive (PCL)2(PDEA-b-PPEGMA)2 mi-
celles would be efficient and hopeful platforms for cancer
therapy.
Additional file
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